Angiosarcoma after revision total knee arthroplasty.


Journal

The Knee
ISSN: 1873-5800
Titre abrégé: Knee
Pays: Netherlands
ID NLM: 9430798

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 08 05 2020
revised: 04 11 2020
accepted: 23 11 2020
pubmed: 29 12 2020
medline: 22 6 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Hemarthrosis after total knee arthroplasty (TKA) is a relatively rare complication. Although most cases are effectively treated with conservative therapy, some cases require angiographic embolization or surgical intervention. Angiosarcoma is a rare malignant tumor derived from the vascular endothelium with neovascular hyperplasia and mainly arises in the skin and superficial soft tissue, and less frequently in deep soft tissue and bone. Although malignant neoplasms such as angiosarcoma in the vicinity of orthopedic implants were reported, the causal relationship between development of the malignant tumor and the orthopedic implant is widely debated in the literature. We report the case of a 68-year-old female with angiosarcoma that developed in the knee joint 2 years after revision TKA. The patient exhibited severe persistent bleeding, which reached 1000-1400 ml per day for 4 months. Histological analysis of the synovial tissue in the knee joint showed large cells with nuclear atypia. Immunohistochemical staining showed cells that were positive for CD31, CD34, and D2-40, and she was diagnosed with angiosarcoma. The patient underwent an amputation at the level of the thigh, and her general condition immediately improved after the operation. The patient did not exhibit bleeding from the site of amputation, and no local recurrence or distant metastases were detected 1 year after the amputation. To the best of our knowledge, this represents the first report of angiosarcoma 2 years after revision TKA. Further careful follow up is needed, given the high-grade malignancy.

Sections du résumé

BACKGROUND BACKGROUND
Hemarthrosis after total knee arthroplasty (TKA) is a relatively rare complication. Although most cases are effectively treated with conservative therapy, some cases require angiographic embolization or surgical intervention. Angiosarcoma is a rare malignant tumor derived from the vascular endothelium with neovascular hyperplasia and mainly arises in the skin and superficial soft tissue, and less frequently in deep soft tissue and bone. Although malignant neoplasms such as angiosarcoma in the vicinity of orthopedic implants were reported, the causal relationship between development of the malignant tumor and the orthopedic implant is widely debated in the literature.
CASE PRESENTATION METHODS
We report the case of a 68-year-old female with angiosarcoma that developed in the knee joint 2 years after revision TKA. The patient exhibited severe persistent bleeding, which reached 1000-1400 ml per day for 4 months. Histological analysis of the synovial tissue in the knee joint showed large cells with nuclear atypia. Immunohistochemical staining showed cells that were positive for CD31, CD34, and D2-40, and she was diagnosed with angiosarcoma. The patient underwent an amputation at the level of the thigh, and her general condition immediately improved after the operation. The patient did not exhibit bleeding from the site of amputation, and no local recurrence or distant metastases were detected 1 year after the amputation.
CONCLUSIONS CONCLUSIONS
To the best of our knowledge, this represents the first report of angiosarcoma 2 years after revision TKA. Further careful follow up is needed, given the high-grade malignancy.

Identifiants

pubmed: 33360381
pii: S0968-0160(20)30392-6
doi: 10.1016/j.knee.2020.11.019
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-158

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ryuichi Fukuda (R)

Department of Orthopedic Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan; Department of Orthopedic Surgery, Teine Keijinkai Hospital, Teine-Ku, Sapporo, Hokkaido, Japan. Electronic address: ryuichi-fkd@dream.jp.

Masatake Matsuoka (M)

Department of Orthopedic Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan. Electronic address: masatakem@pop.med.hokudai.ac.jp.

Tomohiro Onodera (T)

Department of Orthopedic Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan. Electronic address: tomozou@med.hokudai.ac.jp.

Koji Iwasaki (K)

Department of Functional Reconstruction for the Knee Joint, Hokkaido University, Sapporo, Hokkaido, Japan. Electronic address: rockcape324@gmail.com.

Daisuke Tanaka (D)

Department of Orthopaedic Surgery, Eniwa Hospital, Eniwa-Shi, Hokkaido, Japan. Electronic address: dsk.tnk921@gmail.com.

Hiroaki Hiraga (H)

Department of Musculoskeletal Oncology, Hokkaido Cancer Center, Shiroishi-Ku, Sapporo, Hokkaido, Japan. Electronic address: hhiraga@nho-hcc.jp.

Hiromi Kanno-Okada (H)

Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan. Electronic address: kanno-kanno@med.hokudiai.ac.jp.

Yoshihiro Matsuno (Y)

Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan. Electronic address: ymatsuno@med.hokudai.ac.jp.

Eiji Kondo (E)

Centre for Sports Medicine, Hokkaido University Hospital, Sapporo, Hokkaido, Japan. Electronic address: eijik@med.hokudai.ac.jp.

Norimasa Iwasaki (N)

Department of Orthopedic Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan. Electronic address: niwasaki@med.hokudai.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH